NNNN
Anbio Biotechnology
4.05
+0.25 (+6.58%)
52w low 3.09
44.73 high
2.3% of range
Financial Analysis
| (USD) | Jun 25 | Dec 25 | Trend |
|---|---|---|---|
| Cash & Equivalents | 5.35M | 7.77M | |
| Receivables | 3.72M | 3.66M | |
| Current Assets | 27.68M | 30.24M | |
| Total Assets | 27.68M | 30.24M | |
| Current Liabilities | 131.13K | 87.84K | |
| Total Liabilities | 131.13K | 87.84K | |
| Retained Earnings | 20.97M | 23.58M | |
| Shareholders Equity | 27.55M | 30.16M | |
| Working Capital | 27.55M | 30.16M | |
| Shares Outstanding | 43.89M | 43.89M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--